UNSPSC 51434929: Enalapril/hydrochlorothiazide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV400. This VA Drug Class (CV400) classifies this compound as belonging to the group ANTIHYPERTENSIVE COMBINATIONS.

UNSPSC 51434929 Enalapril/hydrochlorothiazide is a Commodity code that encompasses individual pharmaceutical products—in this case, a specific antihypertensive combination drug. Recent state and local procurement activity under this code, however, reflects broader pharmaceutical procurement patterns: state and local buyers source medications in two distinct patterns. Emergency-response agencies such as fire departments solicit individual advanced life support medications for immediate clinical use, specifying unit counts, expiration dates, delivery timelines, and warranty periods. State health agencies and cooperative purchasing alliances, by contrast, conduct large-scale generic pharmaceutical and OTC product procurement through wholesaler networks, establishing master contracts with manufacturer-level pricing and compliance requirements tied to cGMP certification, FDA authorization, and supply-chain security standards. The issuing bodies span municipal fire departments, state health commissions, and state-coordinated multistate cooperative purchasing organizations that aggregate demand across participating government facilities.

Recent activity concentrated in Texas, Minnesota, and Florida between January and April 2026. The City of Tampa's Purchasing Department issued IFB 26P00188 on April 24, 2026 for Advanced Life Support Medications (response due April 8, 2026), soliciting four specific medication line items totaling approximately 3,530 units for Tampa Fire Rescue with a Small Local Business Enterprise set-aside offering a 5 percent bid discount, estimated contract value $40,000. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued RFP S1070000015802 on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across state and local government facilities in Minnesota and Oregon, requiring vendor pricing through three authorized wholesalers and effective July 1, 2026. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026 as exploratory market research into direct-to-manufacturer prescription programs, not a binding solicitation with award values or timelines. The code shows active procurement but with no single dominant issuing body and substantial variance in procurement approach—from emergency-supply IFBs to multistate cooperative master agreements to state-level strategic research initiatives.